Get the Stockscreener App
2.46
21.18%
0.43
Gt Biopharma Inc Stock (GTBP) Latest News
GT Biopharma Retail Chatter Soars Most Among Biotechs After Financing Strategy Tweak - Asianet Newsable
"Signal Advance, Inc. (OTC: SIGL) Achieves Technology - openPR
GT Biopharma announces warrant exercise, plans new offering - Investing.com
GT Biopharma announces warrant exercise, plans new offering By Investing.com - Investing.com UK
GT Biopharma Announces Exercise of Warrants - GlobeNewswire
GT Biopharma's Financial Maneuver: $0.7M Cash Influx Comes With 604K New Warrants - StockTitan
Stock market today: Wah Fu Education Group +219.55%, Jet.AI +46.26% among top gainers in early trading - Business Upturn
Artificial Intelligence (AI) News Live Feed - StockTitan
GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement - The Manila Times
GT Biopharma withdraws SEC registration statement - Investing.com
GT Biopharma Pulls Back S-1 Filing: What Does This Mean for Their Financing Strategy? - StockTitan
GT Biopharma, Inc. SEC 10-K Report - TradingView
This New Nasdaq Biotech Could Revolutionize Emergency Cardiac CareHere's Why - StockTitan
Short Interest in GT Biopharma, Inc. (NASDAQ:GTBP) Expands By 5.1% - Defense World
Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven - Yahoo Finance
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily
GT Biopharma Announces Recently Presented Data on Our Next Generation TriKE (OXS-C3550) at The Ash Meeting in Atlanta, GA - ACCESS Newswire
Nanobodies Market Analysis: Growth Drivers in Targeted - openPR
Pre-market Movers In Healthcare Sector: HUGE, ONTX, SVRA, CELC, CHFS... - RTTNews
StockNews.com Initiates Coverage on Beasley Broadcast Group (NASDAQ:BBGI) - Defense World
StockNews.com Begins Coverage on Ayala Pharmaceuticals (NASDAQ:ADXS) - Defense World
Barnes Group (NYSE:B) Now Covered by StockNews.com - Defense World
Apollo Commercial Real Estate Finance (NYSE:ARI) Stock Rating Lowered by StockNews.com - Defense World
KULR Technology Group Announces Strategic Partnership with EDOM Technology - Defense World
StockNews.com Begins Coverage on Power REIT (NYSE:PW) - Defense World
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World
Embrace Change Acquisition Corp. Enters Definitive Merger Agreement with Tianji for Public ListingSAN DIEGO, CA – January 27, 2025 – Embrace Change Acquisition Corp. (NASDAQ: EMCGU), a special purpose acquisition company, and Tianji Tire Global - Defense World
Goldman Sachs Announces Adoption of Tax Benefit Preservation Plan - Defense World
First Financial Bancorp Reports Solid Financial Performance in Fourth Quarter 2024 - Defense World
Seaport Res Ptn Forecasts Weaker Earnings for Sands China - Defense World
Galectin Therapeutics Inc. Reports Results from 2024 Annual Meeting in Recent 8-K Filing - Defense World
Cormark Weighs in on Real Matters’ FY2025 Earnings (TSE:REA) - Defense World
AmpliTech Group, Inc. (NASDAQ:AMPG) Short Interest Down 60.9% in January - Defense World
GT Biopharma Announces First Patient Dosed in Phase 1 Trial - GlobeNewswire
GT Biopharma Announces Expanded TriKE(TM) Partnership With Cytovance Biologics - ACCESS Newswire
GT Biopharma, Inc. Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies - Marketscreener.com
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies - The Manila Times
GT Biopharma Initiates Phase 1 Trial of Advanced TriKE Therapy for Blood Cancers - StockTitan
GT Biopharma Provides Update Concerning Trike(TM) Drug Development Programs and Other Strategic Initiatives - ACCESS Newswire
GT Biopharma Announces Completion of $5.6 Million Bridge Financing - ACCESS Newswire
GT Biopharma Announces Dr. Greg Berk, M.D. Joins Board of Directors - ACCESS Newswire
UPDATE: GT Biopharma Announces Preliminary Results for GTB-3550 TriKE(TM) Phase I/II Clinical Trial for Treatment of Acute Myeloid Leukemia - ACCESS Newswire
GT Biopharma Hires Chief Medical Officer Jeffery Miller, M.D. - ACCESS Newswire
GT Biopharma and Cytovance Biologics Announce Collaboration Agreement TriKE(TM) Therapeutic for Treatment of Coronavirus Infection - ACCESS Newswire
GT Biopharma Announces Preliminary Results for GTB-3550 TriKE(TM) Phase I/II Clinical Trial for Treatment of Acute Myeloid Leukemia - ACCESS Newswire
Nanobodies Market Generated Opportunities, Future Scope - openPR
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Pre-market Movers: SAGE, ITCI, GCTK, MRNA... - RTTNews
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida - Yahoo Finance
Nanobodies Market reached US$ 502.60 million in 2023 and - openPR
Argent BioPharma Ltd. Raised US$4,500,000 - Yahoo Finance
Biotech Stocks Surging in September - AccessWire
Maryland Biotech Gains Regulatory Approval - Streetwise Reports
GT Biopharma files automatic mixed securities shelf - MSN
FDA Tracker: 2024 Ends With Lilly’s Landmark GLP-1 Sleep Apnea Approval - BioSpace
Stock market today: Traws Pharma +231.47%, Rumble +59.02% among top gainers in early trading - Business Upturn
First Heartland Consultants Inc. Sells 10,222 Shares of Amazon.com, Inc. (NASDAQ:AMZN) - Defense World
Nk Cell Therapy Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Artiva Biotherapeutics, Dragonfly therapeutics, Affimed, XNK Therapeut - Barchart
GTBP Stock Hits 52-Week Low at $1.92 Amid Market Challenges - Investing.com
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):